Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A3284 Cathepsin S inhibitor1 CitationTarget: CathepsinsSummary: Blocks MHCII antigen presentation
-
A1903 E 64d4 CitationSummary: Cysteine protease inhibitor
-
A1926 CA 0742 CitationTarget: CathepsinsSummary: Cathepsin B inhibitor
-
A8162 E-64-cTarget: cysteine proteaseSummary: Inhibitor of cysteine proteinases
-
A2576 E-642 CitationTarget: Cathepsins|Calpains|PapainsSummary: Cysteine protease inhibitor,irriversible
-
A8174 Cathepsin G Inhibitor ITarget: CathepsinsSummary: Cathepsin G inhibitor
-
A4422 L 006235Summary: Cathepsin K inhibitor
-
A4412 MDL 28170Target: Cathepsins|CalpainsSummary: Calpain and cathepsin B inhibitor, selective
-
A4424 SID 26681509Target: CathepsinsSummary: Human cathepsin L inhibitor,potent and reversible
-
A8239 CA-074 Me7 CitationTarget: CathepsinsSummary: Cathepsin B inhibitor